FASN and cholangiocarcinoma: In cholangiocarcinoma, the knockdown of FASN suppresses cell growth, migration, and invasion, which is associated with decreased cellular levels of palmitic amide, a fatty acid amide derived from palmitic acid (Tomacha et al. 2021).